Skip to content

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07011836
Acronym
mNav
Enrollment
288
Registered
2025-06-10
Start date
2025-07-01
Completion date
2027-03-31
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Neoplasms

Keywords

Early Detection of Cancer, Health Behavior, Patient Navigation, African Americans

Brief summary

The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African American women who are currently overdue for screening. The main questions it aims to answer are: Can an interactive video navigation tool (mNav), when paired with in-person navigation, improve screening adherence compared to a standard educational video alone? Does the intervention improve knowledge, reduce barriers, and increase intentions to get screened? Researchers will compare participants who receive both the interactive video (guided by an on-screen navigator) and in-person navigation to those who receive only a standard educational video to see if the tailored support increases screening rates. Participants will: Complete two phone surveys (one at the beginning and one six months later) Be randomly assigned to one of two groups: One group will receive an interactive video experience tailored to their concerns plus support from an in-person navigator The other group will receive a standard educational video designed for African American women Have their clinic records reviewed six months later to check for cervical cancer screening completion

Interventions

BEHAVIORALmNav Interactive Video + Navigator

A personalized, video-based tool paired with navigator support to address individual screening barriers.

BEHAVIORALEducational Video

A culturally tailored cervical cancer education video without additional support or tailoring.

Sponsors

ISA Associates, Inc.
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Black or African American woman * Nonadherent to USPSTF cervical cancer screening guidelines (no Pap test in the past 3 years or no HPV test in the past 5 years) * Age 21 to 65 years old * Not currently pregnant * No history of hysterectomy * Access to a mobile phone capable of receiving text messages and watching video content

Exclusion criteria

\*None

Design outcomes

Primary

MeasureTime frameDescription
Completion of Cervical Cancer ScreeningWithin 6 months of enrollmentWhether participants completed cervical cancer screening, as verified through medical record review. Screening includes a Pap test, HPV test, or co-test, consistent with current guidelines.

Secondary

MeasureTime frameDescription
Cervical Cancer Screening IntentionBaseline and 6-month follow-upMeasures participants' self-reported likelihood of obtaining cervical cancer screening in the next 6 months. This is a single-item Likert scale ranging from 0 to 4, with higher scores indicating a greater likelihood of screening. Scale anchors are: 0 = Not at all likely, 1 = A little likely, 2 = Somewhat likely, 3 = Likely, 4 = Very likely.
Cervical Cancer Knowledge ScaleBaseline and 6-month follow-upAssessed using a structured survey at baseline and follow-up, this 20-item True/False scale evaluates participant knowledge of cervical cancer risks, screening methods, and guidelines. Scale scores range from 0 to 20, with higher scores indicating greater knowledge. Each correct response is scored as 1; incorrect or missing responses are scored as 0. The total score represents the number of correct responses.

Countries

United States

Contacts

CONTACTDouglas Billings, PhD
dbillings@isagroup.com7037390882

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026